Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Grever

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Pentostatin in the treatment of advanced hairy cell leukemiaE H Kraut, B A Bouroncle, M R Grever
Seminars in Oncology|December 1, 1992
The National Cancer Institute: cancer drug discovery and development programM R Grever, S A Schepartz, B A Chabner
Blood|December 15, 1994
Long-term follow-up of patients with hairy cell leukemia after treatment with 2'-deoxycoformycinE H Kraut, M R Grever, B A Bouroncle
Blood|February 1, 1983
Differential excretion of modified nucleosides in adult acute leukemiaD A Heldman, M R Grever, R W Trewyn
Biometrics|December 1, 1984
A biological marker model for predicting disease transitionsJ P Klein, J H Klotz, M R Grever
Journal of the National Cancer Institute|July 6, 1994
An added dimension: will three-dimensional cultures improve our understanding of drug resistance?P S Steeg, M C Alley, M R Grever
Leukemia|April 1, 1987
Treatment of hairy cell leukemia: the Ohio State University experience with deoxycoformycinB A Bouroncle, M R Grever, E H Kraut
Seminars in Oncology|October 1, 1990
Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphateL Malspeis, M R Grever, A E Staubus, et al.
Investigational New Drugs|January 1, 1997
A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcomaM L Keohan, M R Grever, S P Balcerzak, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agentJ G Supko, R L Hickman, M R Grever, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Pentostatin in the treatment of advanced hairy cell leukemiaE H Kraut, B A Bouroncle, M R Grever
Seminars in Oncology|December 1, 1992
The National Cancer Institute: cancer drug discovery and development programM R Grever, S A Schepartz, B A Chabner
Blood|December 15, 1994
Long-term follow-up of patients with hairy cell leukemia after treatment with 2'-deoxycoformycinE H Kraut, M R Grever, B A Bouroncle
Blood|February 1, 1983
Differential excretion of modified nucleosides in adult acute leukemiaD A Heldman, M R Grever, R W Trewyn
Biometrics|December 1, 1984
A biological marker model for predicting disease transitionsJ P Klein, J H Klotz, M R Grever
Journal of the National Cancer Institute|July 6, 1994
An added dimension: will three-dimensional cultures improve our understanding of drug resistance?P S Steeg, M C Alley, M R Grever
Leukemia|April 1, 1987
Treatment of hairy cell leukemia: the Ohio State University experience with deoxycoformycinB A Bouroncle, M R Grever, E H Kraut
Seminars in Oncology|October 1, 1990
Pharmacokinetics of 2-F-ara-A (9-beta-D-arabinofuranosyl-2-fluoroadenine) in cancer patients during the phase I clinical investigation of fludarabine phosphateL Malspeis, M R Grever, A E Staubus, et al.
Investigational New Drugs|January 1, 1997
A phase II Southwest Oncology Group study of cisplatin and continuous infusion vinblastine in the treatment of advanced soft tissue sarcomaM L Keohan, M R Grever, S P Balcerzak, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Preclinical pharmacologic evaluation of geldanamycin as an antitumor agentJ G Supko, R L Hickman, M R Grever, et al.
Pageof 10